Compare Nomura Holdings Inc (NMR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs Twist Bioscience Corp — how do they compare? Nomura Holdings Inc trades at $9.4 (market cap $27.46B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Nomura Holdings Inc is far larger — about 5× Twist Bioscience Corp's market cap, and Nomura Holdings Inc pays a 3.45% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NMR | TWST | |
|---|---|---|
Market Cap | $27.46B | $5.45B |
Sector | Financials | Health |
52-Week High | $10.04 | $102.88 |
52-Week Low | $6.39 | $24.16 |
Dividend Yield | 3.45% | — |
Enterprise Value | — | $5.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
